Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
Abstract Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of GO in Europe may be declining, however data on the prevalence of this...
Main Authors: | P. Perros, L. Hegedüs, L. Bartalena, C. Marcocci, G. J. Kahaly, L. Baldeschi, M. Salvi, J. H. Lazarus, A. Eckstein, S. Pitz, K. Boboridis, P. Anagnostis, G. Ayvaz, A. Boschi, T. H. Brix, N. Currò, O. Konuk, M. Marinò, A. L. Mitchell, B. Stankovic, F. B. Törüner, G. von Arx, M. Zarković, W. M. Wiersinga |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-017-0625-1 |
Similar Items
-
Steroid-resistant Graves' orbitopathy: Therapeutic options
by: Klet Sanja, et al.
Published: (2023-01-01) -
Graves'orbitopathy: current imaging procedures
by: E Kirsch, et al.
Published: (2009-10-01) -
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01) -
Antioxidant Therapy in Graves’ Orbitopathy
by: Giulia Lanzolla, et al.
Published: (2020-12-01) -
Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01)